beta-thujaplicin has been researched along with Age-Related Osteoporosis in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoporosis is a metabolic bone-loss disease characterized by abnormally excessive osteoclast formation and bone resorption." | 1.62 | Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo. ( Fu, Z; Li, X; Qian, Y; Sun, P; Wang, K; Wang, Y; Yang, Q; Zhang, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Yang, Q | 1 |
| Fu, Z | 1 |
| Sun, P | 1 |
| Zhang, T | 1 |
| Wang, K | 1 |
| Li, X | 1 |
| Qian, Y | 1 |
1 other study available for beta-thujaplicin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo.
Topics: Actins; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Line; Disease Models, Anima | 2021 |